scispace - formally typeset
R

Ronald G. Tompkins

Researcher at Harvard University

Publications -  531
Citations -  44641

Ronald G. Tompkins is an academic researcher from Harvard University. The author has contributed to research in topics: Burn injury & Poison control. The author has an hindex of 93, co-authored 526 publications receiving 41859 citations. Previous affiliations of Ronald G. Tompkins include University of Toronto & Tulane University.

Papers
More filters
Journal ArticleDOI

Long-term consequences of toxic epidermal necrolysis in children.

TL;DR: Survival has improved in children with TEN, but long-term sequelae are not infrequent, including the eyes, the skin, and the nails; the most common long- Term morbidity involved eyes, nails, and variegated skin depigmentation.
Journal ArticleDOI

Developing Effective Alzheimer's Disease Therapies: Clinical Experience and Future Directions.

TL;DR: Alzheimer’s disease clinical trials, focused on disease modifying drugs and conducted in patients with mild to moderate AD, as well as prodromal AD, have failed to reach efficacy endpoints in improving cognitive function in most cases to date or have been terminated due to adverse events.
Journal Article

Autoradiographic method for quantitation of radiolabeled proteins in tissues using indium-111.

TL;DR: A quantitative autoradiographic method was developed to measure 111In-labeled proteins in extravascular tissues with a spatial resolution sufficient to associate these proteins with tissue morphology, and significantly higher average tissue concentrations were found in the infected thighs.
Journal ArticleDOI

Cultured autologous epithelium in patients with burns of ninety percent or more of the body surface.

TL;DR: CAE can materially contribute to wound closure in patients with very extensive burns, but gram-negative sepsis is associated with complete graft loss, and such liabilities become more tolerable as usable donor site decreases below 5% to 10% of the body surface.
Journal ArticleDOI

Early elevation in random plasma IL-6 after severe injury is associated with development of organ failure

TL;DR: Elevation in plasma IL-6 seems to correlate with a poor prognosis, so this measurement may be useful as a biomarker for prognosis and serve to identify patients at higher risk of adverse outcome that would benefit from novel therapeutic interventions.